(0.31%) 5 115.72 points
(0.31%) 38 357 points
(0.34%) 15 982 points
(-0.88%) $83.11
(5.77%) $2.03
(0.39%) $2 356.30
(0.50%) $27.67
(4.05%) $959.45
(-0.22%) $0.933
(-0.38%) $10.98
(-0.54%) $0.796
(1.69%) $93.43
Live Chart Being Loaded With Signals
Centogene N.V., together with its subsidiaries, focuses on rare diseases that transforms real-world clinical and genetic, or other data into actionable information for patients, physicians, and pharmaceutical companies worldwide...
Stats | |
---|---|
本日の出来高 | 14 880.00 |
平均出来高 | 59 656.00 |
時価総額 | 13.11M |
EPS | €0 ( 2023-12-28 ) |
次の収益日 | ( €-0.340 ) 2024-05-21 |
Last Dividend | €0 ( N/A ) |
Next Dividend | €0 ( N/A ) |
P/E | -0.300 |
ATR14 | €0.0120 (2.55%) |
Centogene NV 相関
10 最も負の相関 | |
---|---|
TSLA | -0.906 |
PPBT | -0.898 |
SNCR | -0.892 |
CRSA | -0.884 |
LMNL | -0.878 |
TCRX | -0.86 |
FIZZ | -0.852 |
CINC | -0.84 |
BNIXU | -0.832 |
MVBF | -0.826 |
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
Centogene NV 財務諸表
Annual | 2022 |
収益: | €47.47M |
総利益: | €19.76M (41.63 %) |
EPS: | €-1.440 |
FY | 2022 |
収益: | €47.47M |
総利益: | €19.76M (41.63 %) |
EPS: | €-1.440 |
FY | 2021 |
収益: | €189.92M |
総利益: | €28.16M (14.83 %) |
EPS: | €-2.06 |
FY | 2020 |
収益: | €128.38M |
総利益: | €42.00M (32.72 %) |
EPS: | €-1.020 |
Financial Reports:
No articles found.
Centogene NV
Centogene N.V., together with its subsidiaries, focuses on rare diseases that transforms real-world clinical and genetic, or other data into actionable information for patients, physicians, and pharmaceutical companies worldwide. It operates through three segments: Pharmaceutical, Diagnostics, and COVID-19 testing. The company develops rare disease platform, a data and biological repository, which includes epidemiologic, phenotypic, and heterogenetic data that enhances methods for identifying and monitoring rare hereditary diseases and provide solutions that accelerate the development of orphan drugs. It provides various services, including target discovery, early patient recruitment and identification, epidemiological insights, biomarker discovery, and patient monitoring; and genetic sequencing and diagnostics services to physicians, laboratories, or hospitals directly or through distributors. The company also offers COVID-19 testing solutions, including PCR and antigen testing services. It has collaboration and license agreements with Shire International GmbH, Pfizer Inc., Dr. Bauer Laboratoriums GmbH, Fraport AG, Takeda Pharmaceutical Company Limited, and Twist Bioscience Corporation. Centogene N.V. was founded in 2006 and is headquartered in Rostock, Germany.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。